Company

HutchMed Shifts Focus to Late-Stage Pipeline for Regulatory Approvals

CompanyDeals

Harbour BioMed and WuXi Biologics Announce Strategic Collaboration

CompanyDrug

Hengrui’s Pyrotinib Granted Priority Review for HER2-Positive Breast Cancer

Policy / Regulatory

CDE Issues Guidelines for Bispecific Antibody Antitumor Drug Development

CompanyDrug

AstraZeneca to Launch Soliris in Hangzhou After Regulatory Approval

CompanyDrug

Akeso Biopharma’s AK112 Receives Two New Breakthrough Therapy Designations

Company

CStone Launches Patient Assistance Program for IDH1 Inhibitor Tibsovo

CompanyDrug

HutchMed Announces Initial Results from FRUTIGA Phase III Study

CompanyDeals

BRL Medicine Raises RMB 200M in Series B Financing for CGT Development

CompanyMedical Device

Peijia Medical Enrolls First Patient in HighLife TSMVR Study

CompanyMedical Device

Acotec Scientific Secures FDA 510(k) Approval for Vericor Catheter

Company

CStone Pharmaceuticals Suspends Operations at Suzhou Plant to Cut Costs